Eisai Innovation, Inc. and MBC BioLabs are happy to announce Deciduous Therapeutics as the winner of their 2021 Golden Ticket Competition. Eisai Innovation, Inc.'s inaugural competition provides the winning company's entrepreneurial scientists and emerging biotechnology start-up with lab space in the MBC BioLabs facility to pursue drug discovery and innovation for the potential future benefit of patients worldwide.
Entries were received across a broad range of disease areas and included a number of exciting innovative technologies. Deciduous Therapeutics was selected for their innovative technology of selectively removing senescent cells to deliver therapeutic advances for unmet medical needs in age-related diseases. As the winner, they will have one-year free access to MBC BioLabs' state-of-the-art laboratory facility.